PMC · DOI:10.1111/cas.16081·January 25, 2024
Correction to: TAS2940, A novel brain‐penetrable pan‐ERBB inhibitor, for tumors with HER2 and EGFR aberrations
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProtein Degradation and Inhibitors · PARP inhibition in cancer therapy · Ubiquitin and proteasome pathways